Prashanjit Roy

Prashanjit Roy

Auto-generated profile, based on publicly available information

Prashanjit Roy

Department of Pharmacy Practice, ISF College of Pharmacy, Moga Punjab, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Current Cardiology Reviews
Verified
Journal Article
Open access
PDF file
PRPrashanjit Roy
Prashanjit Roy
RKRishi Kant
Rishi Kant
AKAmandeep Kaur
Amandeep Kaur
HKHardik Kumar
Hardik Kumar
RKRanjeet Kumar
Ranjeet Kumar
Leptin, a hormone produced by fat cells, is crucial for regulating energy equilibrium, managing body mass, and influencing metabolic and cardiovascular well-being. Leptin decreases appetite, boosts energy usage, and has a significant impact on glucose metabolism by primarily activating the JAK2/STAT3 signaling pathway in the hypothalamus. Obesity leads to the development of leptin resistance, which is marked by high levels of leptin in the bloodstream and a decreased responsiveness to its signals. This leads to increased food consumption, weight gain, and metabolic issues, such as type 2 diabetes (T2DM) and cardiovascular disease (CVD). This study explores the many roles of leptin in metabolic regulation, with a specific emphasis on its interaction with insulin and its impact on peripheral organs like the pancreas, liver, and muscles. Leptin resistance worsens chronic inflammation, oxidative stress, endothelial dysfunction, and insulin resistance, all of which are strongly linked to the development of cardiovascular disease (CVD). Moreover, there is a correlation between genetic variations in the leptin receptor (LEPR) gene and a higher susceptibility to stroke and other cardiovascular issues. Therapeutic interventions, such as leptin replacement therapy, have demonstrated potential in the treatment of congenital leptin insufficiency and lipodystrophy while also enhancing glycaemic control, lipid profiles, and neuroendocrine function. Recent studies have indicated that manipulating leptin levels or enhancing its responsiveness by specific treatments, such as chemical chaperones and inhibitors of negative regulators like SOCS3 and PTP1B, might potentially restore the efficacy of leptin.

4 May 2026 in Current Hypertension Reviews
Verified
Journal Article
Closed access
PDF file
RKRishi Kant
Rishi Kant
PRPrashanjit Roy
Prashanjit Roy
AKAmandeep Kaur
Amandeep Kaur
PRPrincy Rs
Princy Rs
SKSourabh Kosey
Sourabh Kosey
RKRanjeet Kumar
Ranjeet Kumar
The article investigates the crucial roles of oxidative stress and inflammation in the progression of Chronic Kidney Disease (CKD), a condition that poses an increasing global health burden. An imbalance between reactive oxygen species (ROS) and antioxidant defenses leads to mitochondrial damage, which subsequently triggers endothelial dysfunction and promotes kidney fibrosis. CKD symptoms are further exacerbated by inflammation, driven by uremic toxins and cytokine activity. The article highlights NF-κB and Nrf2 as key signaling pathways that regulate these networks. Additionally, it examines how cardiovascular disease, mineral-bone disorder, and cognitive decline emerge as clinical consequences of inflammatory and oxidative tissue damage. Therapeutic strategies for CKD are categorized into three main approaches: antioxidants and anti-inflammatory medications, SGLT2 inhibitors, and bardoxolone methyl. The article also emphasizes non-pharmacological interventions, including behavioral modifications, dietary adjustments, probiotic use, and modulation of the gut microbiota. Finally, it discusses emerging research on biomarker development, precision medicine techniques, and genetic therapies aimed at improving CKD detection, management, and treatment outcomes